Bo Hu

Dr. Bo Hu serves as a Research Associate Professor in the Department of Neurology at Northwestern University Feinberg School of Medicine, specializing in neuro-oncology with a focus on adult and pediatric brain tumor research. Her work centers on tumor biology, therapy development, and molecular mechanisms of cancer progression.

Her academic credentials include:

• BS from Shanghai First Medical University (1982)
• MS from Tongji Medical University (1986)
• PhD from Ohio State University (1992)
• Postdoctoral training in Biochemistry at University of California, San Diego (1994)

Dr. Hu's research integrates molecular biology, RNA mechanisms, and tumor microenvironment studies to develop novel cancer therapies. She investigates pathways driving glioblastoma growth, therapy resistance, and immune interactions, with recent work extending to breast cancer models. Her laboratory focuses on translational applications of circRNA biology and signaling inhibition to overcome treatment barriers.

Analysis of her 2025 publications reveals consistent emphasis on targeting receptor tyrosine kinase pathways (PDGFRα, EGFRvIII) and RNA-mediated mechanisms across brain and breast cancers. Key themes include nanoparticle delivery systems, radiotherapy enhancement, and immune modulation strategies to improve therapeutic efficacy.

Dr. Hu leads an active neuro-oncology research program with sustained publication output (90+ articles) and institutional recognition for discoveries in glioma therapeutic targets. Her work has generated Northwestern University news coverage on novel genetic mechanisms in glioma, glioblastoma cell division blocking, and tumor survival pathways.

She maintains a research laboratory focused on brain tumor biology within the Neuro-oncology division, with ongoing projects exploring molecular targeting strategies and therapeutic combinations for malignant gliomas.